Ethical and Practical Implications of the Human Genome Initiative for Family Medicine
S. Van McCrary, PhD, JD, MPH;
Bill Allen, JD;
Ray Moseley, PhD;
Lee A. Crandall, PhD;
Harry Ostrer, MD;
R. Whit Curry, MD;
Marvin A. Dewar, MD, JD;
David Nye, PhD
Arch Fam Med. 1993;2(11):1158-1163.
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Council on Ethical and Judicial Affairs, American Medical Association. Use of genetic testing by employers. JAMA. 1991;266:1827-1830.
FREE FULL TEXT
2. Juengst ET. The Human Genome Project and bioethics. Kennedy Inst Ethics J. 1991;1:71-74.
3. Rogers JC, Rohrbaugh M. The SAGE-PAGE trial: do family genograms make a difference? J Am Board Fam Pract. 1991;4:319-326.
4. Whittaker LA. The implications of the Human Genome Project for family practice. J Fam Pract. 1992;35:294-301.
5. Gilbert W. DNA sequencing, today and Tomorrow. Hosp Pract. 1991;26:129-138.
6. Moseley R, McCrary SV, Allen WL, et al. The Ethical, Legal, and Social Implications of the Human Genome Initiative for Health Insurance: Policy Analysis and Recommendations. Gainesville, Fla: The Human Genome Insurance Project; 1993. 7. Ostrer H, Allen WL, Crandall LA, et al. Insurance and genetic testing: where are we now? Am J Hum Genet. 1993;52:565-577.
8. Jonsen AR, Siegler M, Winslade WJ. Clinical Ethics. 2nd ed. New York, NY: Macmillan Publishing Co Inc; 1986:61-65. 9. Kratka J. For Their Eyes Only: The Insurance Industry and Consumer Privacy. Boston: Massachusetts Public Interest Research Group; 1990. 10. McGann V H & H Music, 946 F2d 401 (5th Cir 1991), cert denied, 61 USLW 3352 (1992).